Compare ALLO & CMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALLO | CMCL |
|---|---|---|
| Founded | 2017 | 1992 |
| Country | United States | Jersey |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 539.4M | 552.3M |
| IPO Year | 2018 | 2003 |
| Metric | ALLO | CMCL |
|---|---|---|
| Price | $2.32 | $24.88 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 15 | 1 |
| Target Price | $8.35 | ★ $28.00 |
| AVG Volume (30 Days) | ★ 14.4M | 135.3K |
| Earning Date | 05-12-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 2.28% |
| EPS Growth | ★ 34.09 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $38.54 |
| Revenue Next Year | $142,416.42 | N/A |
| P/E Ratio | ★ N/A | $10.88 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.86 | $12.35 |
| 52 Week High | $4.46 | $38.75 |
| Indicator | ALLO | CMCL |
|---|---|---|
| Relative Strength Index (RSI) | 47.27 | 50.20 |
| Support Level | $1.92 | $23.10 |
| Resistance Level | $2.71 | $26.52 |
| Average True Range (ATR) | 0.35 | 1.05 |
| MACD | -0.04 | 0.14 |
| Stochastic Oscillator | 17.82 | 49.64 |
Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.
Caledonia Mining Corp PLC is a gold exploration, development, and mining company. The company's segment includes Blanket, South Africa, Bilboes Oxide mine, and E&E projects. The company generates the majority of its revenue from the Blanket project. The Blanket Mine is located in the south-west of Zimbabwe and operates at a depth of approximately 750 meters below the surface. The company's project includes Maligreen and Motapa.